Keyphrases
Avonex
7%
Betaferon
7%
Binding Antibodies
7%
Biological Activity
7%
CD4+ T Cells
7%
Clinical Observation
7%
Drug Class
7%
Enhanced Immunogenicity
7%
Human Immune System
7%
Human Proteins
14%
Hybrid Mice
21%
Hybrid Progeny
7%
Immune Memory
7%
Immune Response
21%
Immune Tolerance
21%
Immune-tolerant
100%
Immunogenic
21%
Immunogenicity
100%
Immunological Response
7%
Interferon beta-1a
21%
Interferon-β (IFN-β)
100%
Marketed Products
7%
Mechanistic Insight
7%
Mechanistic Studies
100%
Metal Microparticle
7%
Mouse Model
21%
Multiple Sclerosis
7%
MZ B Cells
7%
Native-like
7%
Neutralizing Antibodies
7%
Polystyrene
7%
Prolonged Treatment
7%
Protein Aggregates
7%
Protein Formulation
7%
Protein Immunogenicity
7%
Protein Structure
7%
Rebif
7%
Recombinant Human
14%
Recombinant Human Interferon beta
100%
Recombinant Interferon
100%
Subvisible Particulates
7%
Surface Material
7%
Therapeutic Proteins
7%
Transgenic
100%
Transgenic Hybrid
7%
Transgenic Mice
28%
Transgenic Mouse Model
7%
β-aggregates
100%
Immunology and Microbiology
B Cell
7%
Binding Antibody
7%
Biological Activity
7%
FVB/N Mouse
14%
Human Interferon
21%
Hybrid Mouse Strain
21%
Immune Response
21%
Immune System
7%
Immune Tolerance
21%
Immunogenicity
100%
Immunological Memory
7%
Interferon Beta 1a
28%
Interferon Beta 1b
14%
Monospecific Antibody
14%
Mouse
100%
Mouse Model
21%
Multiple Sclerosis
7%
Neutralizing Antibody
7%
Progeny
7%
Protein Structure
7%
Recombinant Beta Interferon
100%
Surface Property
7%
T-Helper Cell
7%
Transgenic Animal
7%
Transgenic Mouse
28%
Transgenics
100%
Pharmacology, Toxicology and Pharmaceutical Science
Beta1a Interferon
28%
Biological Activity
7%
FVB/N Mouse
14%
Human Interferon
21%
Hybrid Mouse Strain
21%
Immunogenicity
100%
Interferon Beta Serine
14%
Microparticle
7%
Mouse
100%
Mouse Model
21%
Multiple Sclerosis
7%
Neutralizing Antibody
7%
Protein Aggregate
7%
Protein Formulation
7%
Recombinant Beta Interferon
100%
Styrofoam
7%
Transgenic Animal
7%
Transgenic Mouse
28%